Abstract | OBJECTIVE: Patients undergoing anaesthesia and surgery frequently complain about postoperative nausea and vomiting ( PONV). Whether pretreatment with H1 and H2 blocking agents reduces the incidence of PONV remains controversial. To answer this question, we performed a randomised, prospective, placebo-controlled clinical study to evaluate the efficacy of a premedication with H1 and H2 receptor antagonists. MATERIAL AND SUBJECTS: 1149 patients (both sexes) undergoing surgery were randomly assigned to three treatment groups and one control group. Patients in the treatment groups were premedicated with the following H1 + H2 receptor antagonists:Group 1 (n = 335): 5 mg/kg cimetidine i.v. + 0.1 mg/kg dimetindene i.v. 20 min before induction of anaesthesiaGroup 2 (n = 337): 1.25 mg/kg ranitidine i.v. + 0.1 mg/kg dimetindene i.v. 20 min before induction of anaesthesiaGroup 3 (n = 316): 300 mg ranitidine p.o. + 0.1 mg/kg dimetindene i.v. 1 to 2 h before induction of anaesthesiaGroup 4 (n = 161): 20 ml saline solution i.v. 20 min before induction of anaesthesiaPatients from the treatment groups 1, 2 and 3 received regional or general anaesthesia depending on the clinical decision. All control patients received general anaesthesia consisting of fentanyl, a thiobarbiturate, enflurane, nitrous oxide, oxygen, and vecuronium. RESULTS: The incidence of nausea and vomiting was 8.5%, 6.8% and 5.4% in patients from the treatment groups (1, 2 and 3) who underwent general anaesthesia (n = 545), with no statistically significant differences between groups. The incidence of nausea and vomiting in the control group (n = 161) was 28.3% ( nausea) and 27.5% ( vomiting), respectively. In patients who underwent regional anaesthesia (n = 443), the incidence of nausea and vomiting was 2.5% and 1.1%, respectively. CONCLUSIONS:
|
Authors | A W Doenicke, R Hoernecke, I Celik |
Journal | Inflammation research : official journal of the European Histamine Research Society ... [et al.]
(Inflamm Res)
Vol. 53 Suppl 2
Pg. S154-8
(Aug 2004)
ISSN: 1023-3830 [Print] Switzerland |
PMID | 15338068
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
|
Copyright | Copyright 2004 Birkhäuser Verlag, Basel |
Chemical References |
- Histamine H1 Antagonists
- Histamine H2 Antagonists
- Placebos
- Dimethindene
- Cimetidine
- Ranitidine
|
Topics |
- Adult
- Cimetidine
(administration & dosage, pharmacology)
- Dimethindene
(administration & dosage, pharmacology)
- Female
- Histamine H1 Antagonists
(administration & dosage, pharmacology)
- Histamine H2 Antagonists
(administration & dosage, pharmacology)
- Humans
- Injections, Intravenous
- Male
- Placebos
- Postoperative Nausea and Vomiting
(prevention & control)
- Preanesthetic Medication
- Ranitidine
(administration & dosage, pharmacology)
- Time Factors
|